These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
365 related articles for article (PubMed ID: 7650384)
41. Complement contributes to protective immunity against reinfection by Plasmodium chabaudi chabaudi parasites. Taylor PR; Seixas E; Walport MJ; Langhorne J; Botto M Infect Immun; 2001 Jun; 69(6):3853-9. PubMed ID: 11349051 [TBL] [Abstract][Full Text] [Related]
42. Differential induction of helper T cell subsets during blood-stage Plasmodium chabaudi AS infection in resistant and susceptible mice. Stevenson MM; Tam MF Clin Exp Immunol; 1993 Apr; 92(1):77-83. PubMed ID: 8096804 [TBL] [Abstract][Full Text] [Related]
43. Th1 and Th2 CD4+ T cell clones specific for Plasmodium chabaudi but not for an unrelated antigen protect against blood stage P. chabaudi infection. Taylor-Robinson AW; Phillips RS Eur J Immunol; 1994 Jan; 24(1):158-64. PubMed ID: 8020550 [TBL] [Abstract][Full Text] [Related]
44. Involvement of gonadal steroids and gamma interferon in sex differences in response to blood-stage malaria infection. Cernetich A; Garver LS; Jedlicka AE; Klein PW; Kumar N; Scott AL; Klein SL Infect Immun; 2006 Jun; 74(6):3190-203. PubMed ID: 16714546 [TBL] [Abstract][Full Text] [Related]
45. Inhibition of murine malaria (Plasmodium chabaudi) in vivo by recombinant interferon-gamma or tumor necrosis factor, and its enhancement by butylated hydroxyanisole. Clark IA; Hunt NH; Butcher GA; Cowden WB J Immunol; 1987 Nov; 139(10):3493-6. PubMed ID: 3119710 [TBL] [Abstract][Full Text] [Related]
46. Toll-like receptor 4, Toll-like receptor 7 and Toll-like receptor 9 agonists enhance immune responses against blood-stage Plasmodium chabaudi infection in BALB/c mice. Gao W; Sun X; Li D; Sun L; He Y; Wei H; Jin F; Cao Y Int Immunopharmacol; 2020 Dec; 89(Pt B):107096. PubMed ID: 33091818 [TBL] [Abstract][Full Text] [Related]
47. B cells are required for the switch from Th1- to Th2-regulated immune responses to Plasmodium chabaudi chabaudi infection. Taylor-Robinson AW; Phillips RS Infect Immun; 1994 Jun; 62(6):2490-8. PubMed ID: 8188374 [TBL] [Abstract][Full Text] [Related]
48. Preclinical approaches to the treatment of metastatic disease: therapeutic properties of rH TNF, rM IFN-gamma, and rH IL-2. Talmadge JE; Black PL; Tribble H; Pennington R; Bowersox O; Schneider M; Phillips H Drugs Exp Clin Res; 1987; 13(6):327-37. PubMed ID: 3115744 [TBL] [Abstract][Full Text] [Related]
49. Role of interferon-gamma and tumor necrosis factor in host resistance to Plasmodium chabaudi AS. Stevenson MM; Tam MF; Nowotarski M Immunol Lett; 1990 Aug; 25(1-3):115-21. PubMed ID: 2126523 [TBL] [Abstract][Full Text] [Related]
50. Inability of interferon-gamma and aminoguanidine to alter Cryptosporidium parvum infection in mice with severe combined immunodeficiency. Kuhls TL; Mosier DA; Abrams VL; Crawford DL; Greenfield RA J Parasitol; 1994 Jun; 80(3):480-5. PubMed ID: 7515109 [TBL] [Abstract][Full Text] [Related]
51. A defect in interleukin-10 leads to enhanced malarial disease in Plasmodium chabaudi chabaudi infection in mice. Li C; Corraliza I; Langhorne J Infect Immun; 1999 Sep; 67(9):4435-42. PubMed ID: 10456884 [TBL] [Abstract][Full Text] [Related]
52. CD4+T cell-dependent effector mechanisms important in the immune response to the erythrocytic stages of Plasmodium chabaudi chabaudi (AS). Simon-Haarhaus B; Langhorne J; Meding S Behring Inst Mitt; 1991 Feb; (88):94-8. PubMed ID: 1904712 [TBL] [Abstract][Full Text] [Related]
54. Granulocyte-macrophage colony-stimulating factor-deficient mice have impaired resistance to blood-stage malaria. Riopel J; Tam M; Mohan K; Marino MW; Stevenson MM Infect Immun; 2001 Jan; 69(1):129-36. PubMed ID: 11119498 [TBL] [Abstract][Full Text] [Related]
55. Genetic control of resistance to murine malaria. Stevenson M; Lemieux S; Skamene E J Cell Biochem; 1984; 24(1):91-102. PubMed ID: 6725423 [TBL] [Abstract][Full Text] [Related]
56. Effects of in vivo administration of anti-IL-10 or anti-IFN-gamma monoclonal antibody on the host defense mechanism against Plasmodium yoelii yoelii infection. Kobayashi F; Ishida H; Matsui T; Tsuji M J Vet Med Sci; 2000 Jun; 62(6):583-7. PubMed ID: 10907683 [TBL] [Abstract][Full Text] [Related]
57. Modulation of experimental blood stage malaria through blockade of the B7/CD28 T-cell costimulatory pathway. Taylor-Robinson AW; Smith EC Immunology; 1999 Mar; 96(3):498-504. PubMed ID: 10233733 [TBL] [Abstract][Full Text] [Related]
58. Iron chelators: correlation between effects on Plasmodium spp. and immune functions. Golenser J; Domb A; Mordechai-Daniel T; Leshem B; Luty A; Kremsner P J Parasitol; 2006 Feb; 92(1):170-7. PubMed ID: 16629332 [TBL] [Abstract][Full Text] [Related]
59. Vaccination with novel immunostimulatory adjuvants against blood-stage malaria in mice. Su Z; Tam MF; Jankovic D; Stevenson MM Infect Immun; 2003 Sep; 71(9):5178-87. PubMed ID: 12933862 [TBL] [Abstract][Full Text] [Related]
60. Role of endogenous gamma interferon in host response to infection with blood-stage Plasmodium chabaudi AS. Stevenson MM; Tam MF; Belosevic M; van der Meide PH; Podoba JE Infect Immun; 1990 Oct; 58(10):3225-32. PubMed ID: 2119342 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]